Preliminary results of a phase II study of neoadjuvant treatment with docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer

被引：0
|
作者：
Perez-Manga, G.
Mendez, M.
Palomero, M. I.
Quiben, R.
Belon, J.
机构：
[1] Hosp Univ Gregorio Maranon, Med Oncol Serv, Madrid, Spain
[2] Hosp Mostoles, Med Oncol Serv, Madrid, Spain
[3] Hosp Univ Virgen Nieves, Med Oncol Serv, Granada, Spain
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [1] Preliminary results of a phase II study of neoadjuvant treatment with docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer
    Pérez-Manga, G
    Méndez, M
    Palomero, MI
    Quibén, R
    Belón, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S230 - S231
  • [2] Preliminary results of a phase II study of neoadjuvant treatment with docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer.
    Manga, GP
    Méndez, M
    Palomero, MI
    Quibén, R
    Belón, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 91S - 91S
  • [3] Phase II study of neoadjuvant docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer (LABC)
    Perez-Manga, G.
    Mendez, M.
    Palomero, M. I.
    Quiben, R.
    Belon, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Perez Manga, Gumersindo
    Khosravi Shahi, Parham
    Mendez Urena, Miguel
    Quiben Pereira, Rosa
    Palomero Plaza, Maria Isabel
    Izarzugaza Peron, Yann
    Gonzalez Del Val, Ricardo
    Belon Carrion, Joaquin
    Perez Canon, Esperanza
    Garcia Alfonso, Pilar
    [J]. BREAST CANCER, 2010, 17 (03) : 205 - 211
  • [5] Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Gumersindo Pérez Manga
    Parham Khosravi Shahi
    Miguel Méndez Ureña
    Rosa Quiben Pereira
    María Isabel Palomero Plaza
    Yann Izarzugaza Peron
    Ricardo González Del Val
    Joaquín Belón Carrión
    Esperanza Pérez Cañón
    Pilar García Alfonso
    [J]. Breast Cancer, 2010, 17 : 205 - 211
  • [6] Phase II study of neoadjuvant treatment with docetaxel, doxorubicin and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Khosravi-Shahi, P.
    Mendez, M.
    Quiben, R.
    Palomero, I.
    Izarzugaza, Y.
    Belon, J.
    Garcia-Alfonso, P.
    Perez-Manga, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase II study of neoadjuvant Docetaxel (T) Doxorubicin (A) and Capecitabine (X) treatment in locally advanced or inflammatory breast cancer. Goti Cooperative Study Group
    Isabel Palomero, Ma
    Belon, Joaquin
    Quiben, Rosa
    Perez-Manga, Gumersindo
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 33 - 33
  • [8] Preliminary results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC).
    Franco, SX
    Perez, A
    Frankel, C
    Tan-Chiu, E
    Schwartzberg, L
    Schwartz, M
    Krill, E
    Jakub, J
    Abramson, N
    Vogel, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 96S - 96S
  • [9] A phase II trial of Neoadjuvant docetaxel and capecitabine for locally advanced breast cancer
    Lebowitz, PF
    Eng-Wong, J
    Swain, SM
    Berman, A
    Merino, MJ
    Chow, CK
    Venzon, D
    Zia, F
    Danforth, D
    Liu, E
    Zujewski, J
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6764 - 6769
  • [10] A phase II study of docetaxel followed by vinorelbine and doxorubicin in the neoadjuvant treatment of locally advanced breast cancer
    Youssef, A. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345